Top address for life science research
Bavaria invests up to 500 million euros in the competitive development of the Martinsried Max Planck Campus into an outstanding international research hub
In the coming years, the life sciences will be the focus of scientific competition - both for attracting outstanding minds as well as in terms of corresponding infrastructures. The Max Planck Society (MPG) has therefore decided to further develop its Martinsried campus into a flagship for life sciences beyond Germany and Europe. The Free State of Bavaria intends to fund the project with up to 500 million euros over the next ten years, subject to the approval of the state parliament. Minister President Markus Söder and Max Planck President Martin Stratmann signed a corresponding Memorandum of Understanding on April 29, 2021 in the Max Planck House in Munich.
The Martinsried site is already a beacon in European biotechnology and characterized by close networking between academic research, medicine, and industry. The majority of the medium-sized companies located here are spin-offs from scientific institutions, many originating from the two Max Planck Institutes of Biochemistry and of Neurobiology in Martinsried. In the past five years alone, 40 new start-ups were founded. Martinsried has thus developed into the Munich biotech center, with almost 100 companies in total to date.